Espinoza Octavio
SEC insider (Form 3/4/5 filer). CIK 0001905248. Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND). 59 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in JUPITER, FL.
Companies Espinoza Octavio has filed insider reports for
- LIGAND PHARMACEUTICALS INC (LGND): Officer, Chief Financial Officer
Espinoza Octavio
CIK: 0001905248
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIGAND PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (59 total)
- Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect3.3K shares at avg. $68.74$230K - Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect7.2K shares at avg. $57.22$410K - Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect31.6K shares at avg. $292.06$9.2M - Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect16.2K shares at avg. $52.84$855K - Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect2.1K shares at avg. $70.04$145K - Aug 12, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect2.9K shares at avg. $55.75$160K - Jun 30, 2026LGND
LIGAND PHARMACEUTICALS INC
OtherDirect17 shares at avg. $160.71$3K - May 27, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect972 shares at avg. $52.84$51K - May 27, 2026LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect764 shares at avg. $63.62$49K - Mar 11, 2026LGND
LIGAND PHARMACEUTICALS INC
SaleDirect3.1K shares at avg. $225.00$688K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 3,348 | $68.74 | $230,142 | Direct |
| Aug 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 7,171 | $57.22 | $410,325 | Direct |
| Aug 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 31,641 | $292.06 | $9,241,229 | Direct |
| Aug 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 16,179 | $52.84 | $854,898 | Direct |
| Aug 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 2,074 | $70.04 | $145,263 | Direct |
| Aug 12, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 2,869 | $55.75 | $159,947 | Direct |
| Jun 30, 2026 | LGND LIGAND PHARMACEUTICALS INC | Other | 17 | $160.71 | $2,732 | Direct |
| May 27, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 972 | $52.84 | $51,360 | Direct |
| May 27, 2026 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 764 | $63.62 | $48,606 | Direct |
| Mar 11, 2026 | LGND LIGAND PHARMACEUTICALS INC | Sale | 3,057 | $225.00 | $687,825 | Direct |
1-10 of 59 transactions